These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15117932)

  • 41. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence and management of drug-resistant enterococcal infections.
    Arias CA; Murray BE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):637-55. PubMed ID: 18847403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN; Alder J; Thorne GM; Tally FP
    J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
    Ashour HM; el-Sharif A
    J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vancomycin therapy in bone and joint infections--looking into the future].
    Krasin E; Goldwirth M; Otremski I
    Harefuah; 2000 Jun; 138(11):994-6. PubMed ID: 10979416
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diffusion in bone tissue of antibiotics].
    Boselli E; Allaouchiche B
    Presse Med; 1999 Dec 18-25; 28(40):2265-76. PubMed ID: 10636023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence.
    Falagas ME; Giannopoulou KP; Ntziora F; Papagelopoulos PJ
    Int J Antimicrob Agents; 2007 Sep; 30(3):202-9. PubMed ID: 17459668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusidic acid in bone and joint infections.
    Atkins B; Gottlieb T
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates.
    Lee CS; Hwang JH; Lee JH; Song SK; Cho JH; Lee JH
    Korean J Intern Med; 2015 Mar; 30(2):262-4. PubMed ID: 25750572
    [No Abstract]   [Full Text] [Related]  

  • 55. Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.
    Akins RL; Haase KK
    Pharmacotherapy; 2005 Jul; 25(7):1001-10. PubMed ID: 16006278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Teicoplanin--home therapy for prosthetic joint infections.
    Davey PG; Rowley DR; Phillips GA
    Eur J Surg Suppl; 1992; (567):23-5. PubMed ID: 1381637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pristinamycin: old drug, new tricks?
    Cooper EC; Curtis N; Cranswick N; Gwee A
    J Antimicrob Chemother; 2014 Sep; 69(9):2319-25. PubMed ID: 24891428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
    Mackintosh CL; White HA; Seaton RA
    J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Microbiological diagnosis of bone-joint infections].
    Marín M; Esteban J; Meseguer MA; Sánchez-Somolinos M
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):534-40. PubMed ID: 20605272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Guidelines for the management of bone and joint infections due to methicillin resistant staphylococci].
    Stamboulian D; Di Stefano C; Nacinovich F; Pensotti C; Marin M; Carbone E;
    Medicina (B Aires); 2002; 62 Suppl 2():5-24. PubMed ID: 12481484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.